Glucosamine and Yaz drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Glucosamine (glucosamine) and Yaz (drospirenone; ethinyl estradiol). Common drug interactions include pulmonary embolism among females and activities of daily living impaired among males.
The phase IV clinical study analyzes what interactions people have when they take Glucosamine and Yaz. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Glucosamine?
Glucosamine has active ingredients of glucosamine. It is often used in joint pain. eHealthMe is studying from 15,547 Glucosamine users. Check the latest studies of Glucosamine.
What is Yaz?
Yaz has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 41,514 Yaz users. Check the latest studies of Yaz.
29 people who take Glucosamine and Yaz together, and have interactions are studied.

What are the common drug interactions of Glucosamine and Yaz, by gender? *:
female:
- Pulmonary embolism (blockage of the main artery of the lung)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Injury
- Pain
- Emotional distress
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- General physical health deterioration (weak health status)
- Fall
- Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
male:
- Activities of daily living impaired
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Peroneal nerve palsy
- Tremor (trembling or shaking movements in one or more parts of your body)
- Vision blurred
- Dysgraphia (impaired ability to learn to write)
- Embolic stroke (stroke due to obstruction due to an embolus)
- Fall
- Gait disturbance
- Haemorrhage (bleeding)
What are the common drug interactions of Glucosamine and Yaz, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Anxiety
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Emotional distress
- General physical health deterioration (weak health status)
- Injury
- Pain
- Cholecystitis chronic (long lasting infection of gallbladder)
- Pulmonary embolism (blockage of the main artery of the lung)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
30-39:
- Pulmonary embolism (blockage of the main artery of the lung)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Abdominal pain
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Cholecystitis acute (rapid infection of gallbladder)
- Emotional distress
- Gallbladder disorder
- General physical health deterioration (weak health status)
- Injury
40-49:
- Pulmonary embolism (blockage of the main artery of the lung)
- Erythema (redness of the skin)
- Fear
- Injury
- Oedema peripheral (superficial swelling)
- Pain
- Peripheral swelling
- Food poisoning (poison in food)
- Nausea (feeling of having an urge to vomit)
- Vomiting
50-59:
n/a
60+:
n/a
What are the existing conditions these people have? *
- Stress And Anxiety: 5 people, 17.24%
- Premenstrual Syndrome: 4 people, 13.79%
- Pain: 4 people, 13.79%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 10.34%
- Heavy Or Prolong Menstrual Bleeding: 3 people, 10.34%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 6.90%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.90%
- Gait Disturbance: 2 people, 6.90%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 6.90%
- Arthropathy: 2 people, 6.90%
* Approximation only. Some reports may have incomplete information.
Do you take Glucosamine and Yaz?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Glucosamine (15,547 reports)
- Yaz (41,514 reports)
Browse all drug interactions of Glucosamine and Yaz:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Glucosamine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Yaz:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Glucosamine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Yaz and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on glucosamine and drospirenone; ethinyl estradiol (the active ingredients of Glucosamine and Yaz, respectively), and Glucosamine and Yaz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Terconazole and Chantix - a second ago
- Drug interactions of Insulin and Xgeva - a second ago
- Drug interactions of Digoxin and Alkeran - a second ago
- Could Yaz cause Dysstasia? - 10 seconds ago
- Drug interactions of Elavil and Actigall - 13 seconds ago
- Drug interactions of Vonjo and Glipizide - 17 seconds ago
- Could Orencia cause Injection Site Nodule? - 17 seconds ago
- Could Lamivudine cause Blood Thyroid Stimulating Hormone Decreased? - 32 seconds ago
- Drug interactions of Indomethacin and Ampyra - 36 seconds ago
- Could Lovenox cause Melaena? - 42 seconds ago